GLYPICAN-3 ENRICHED IN EXOSOMES NOT IN THE MICROVESICLES: A POTENTIAL BIOMARKER FOR HEPATOCELLULAR CARCINOMA

被引：0
作者：
Koksal, Ali Riza [1 ,2 ]
Aydin, Yucel [3 ,4 ]
Lin, Dong [3 ]
Nunez, Kelley [5 ]
Thevenot, Paul [6 ]
Parsi, Mansour A. [2 ]
Cohen, Ari J. [6 ]
Dash, Srikanta [3 ]
机构：
[1] Sisli Hamidiye Etfal Educ & Res Hosp, Dept Gastroenterol & Hepatol, Istanbul, Turkey
[2] Tulane Univ, Sch Med, Gastroenterol & Hepatol, New Orleans, LA 70118 USA
[3] Tulane Univ, Hlth Sci Ctr, Pathol & Lab Med, New Orleans, LA 70118 USA
[4] St Marys Hosp, Internal Med, St Louis, MO USA
[5] Ochsner Hlth Syst, Translat Res, Jefferson, AR USA
[6] Ochsner Hlth Syst, Jefferson, AR USA
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1146
引用
收藏
页码：691A / 692A
页数：2
相关论文
共 50 条
  • [11] Glypican-3 is a potential tumor marker for hepatocellular carcinoma.
    Kleeff, JH
    Zhu, ZW
    Wang, L
    Zimmermann, A
    Korc, M
    Friess, H
    Buchler, MW
    GASTROENTEROLOGY, 2000, 118 (04) : A261 - A261
  • [12] MAY GLYPICAN-3 BE A NOVEL BIOMARKER AND POTENTIAL THERAPEUTIC TARGET IN HEPATOCELLULAR CANCER?
    Ivanova, Irina I.
    JOURNAL OF IMAB, 2018, 24 (01): : 1936 - 1940
  • [13] The role of glypican-3 in hepatocellular carcinoma: Insights into diagnosis and therapeutic potential
    Devan, Aswathy R.
    Nair, Bhagyalakshmi
    Pradeep, Govind K.
    Alexander, Roshini
    Vinod, Balachandran S.
    Nath, Lekshmi R.
    Calina, Daniela
    Sharifi-Rad, Javad
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2024, 29 (01) : 490
  • [14] Glypican-3 as a serum marker for hepatocellular carcinoma
    Capurro, M
    Filmus, J
    CANCER RESEARCH, 2005, 65 (01) : 372 - 372
  • [15] Upregulation of Glypican-3 in Human Hepatocellular Carcinoma
    Beppu, Tetsuya
    Suzuki, Masahiro
    Sugimoto, Kazushi
    Tanaka, Junnichiro
    Tameda, Masahiko
    Inagaki, Yuji
    Kusagawa, Satoko
    Nojiri, Keiichiro
    Yamamoto, Norihiko
    Uchida, Kazuhiko
    Takase, Koujiro
    Shiraki, Katsuya
    GASTROENTEROLOGY, 2012, 142 (05) : S972 - S972
  • [16] Glypican-3 is overexpressed in human hepatocellular carcinoma
    Sung, YK
    Hwang, SY
    Park, MK
    Farooq, M
    Han, IS
    Bae, HI
    Kim, JC
    Kim, M
    CANCER SCIENCE, 2003, 94 (03): : 259 - 262
  • [17] Epigenetic regulation of glypican-3 in hepatocellular carcinoma
    Trinh, Thu L.
    Puszyk, William
    Liu, Chen
    CANCER RESEARCH, 2014, 74 (19)
  • [18] Evaluation of glypican-3 in patients with hepatocellular carcinoma
    Batbaatar, Batchimeg
    Gurbadam, Unenbat
    Tuvshinsaikhan, Odonchimeg
    Narmandakh, Nyam-Erdene
    Khatanbaatar, Gerelee
    Radnaabazar, Munkhbat
    Erdene-Ochir, Dulguun
    Boldbaatar, Minjuur
    Byambaragchaa, Munkhdelger
    Amankyeldi, Yerbolat
    Chogsom, Munkhzaya
    Ganbileg, Nyamsuren
    Batdelger, Amgalantuul
    Demchig, Tserendorj
    Nyam-Osor, Lkham
    Bayartugs, Batsaikhan
    Batmunkh, Enkhtsatsral
    Munkhjargal, Batkhishig
    Lonjid, Tulgaa
    Khasbagana, Batbayar
    Batmunkh, Munkhbat
    Jav, Sarantuya
    Semchin, Munkhbayar
    MOLECULAR AND CLINICAL ONCOLOGY, 2025, 22 (01)
  • [19] Imaging the expression of glypican-3 in hepatocellular carcinoma by PET
    Wang, Zhen
    Han, Yan-Jiang
    Huang, Shun
    Wang, Meng
    Zhou, Wen-Lan
    Li, Hong-Sheng
    Wang, Quan-Shi
    Wu, Hu-Bing
    AMINO ACIDS, 2018, 50 (02) : 309 - 320
  • [20] Glypican-3 as a potential hepatocellular carcinoma peptide vaccine candidate for the Indonesian population
    Angelika
    Parikesit, Arli Aditya
    Jonathan, Michael
    Julianto, Nadya Marcelina
    JOURNAL OF RESEARCH IN PHARMACY, 2022, 26 (04): : 962 - 979
12345